X. Caignet

Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck

D. Vertommen, J. Machiels, P. Roger, 2020, Molecular Cancer Therapeutics.

Metabolic Imaging Using Hyperpolarized Pyruvate–Lactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts

J. Machiels, O. Feron, Patrice D Cani, 2019, Clinical Cancer Research.

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma.

J. Machiels, R. Helaers, M. Vikkula, 2020, Oral oncology.

2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck

V. Grégoire, J. Machiels, N. Michoux, 2018, Oncotarget.

Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck

D. Vertommen, J. Machiels, P. Roger, 2021, Cancers.